Seamless end-to-end logistical coordination in CAR T-cell therapies: on time, tracked and secure

The chimeric antigen receptor (CAR) T-cell journey includes three distinct phases: collecting the patient's white blood cells through apheresis, modifying the patient's T-cells to manufacture the CAR T-cells, and, finally, infusing the new fighter T-cells into the patient. Connecting these three phases for a timely process that optimizes the patient experience requires a well-coordinated logistical system.As the cells are transported from the trial site to the manufacturer and back to the patient, reliable cellular orchestration is an essential part of the journey. Behind the scenes, logistics, operations and systems for CAR T therapies must ensure that patient sample quality is maintained from vein to vein.nique identifiers on the sample, while the COC permanently captures data related to the personnel handling the samples. All entries must be timestamped and securely stored for easy access.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/whitepapers/Logistical-Coord-CAR-T-Cell-Therapies-WPCGT003.pdf